1.Siegel RL, Miller KD, Jemal A: Cancer statistics, 2016. CA Cancer J Clin 2016, 66(1):7–30.
2.Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J: Cancer statistics in China, 2015. CA Cancer J Clin 2016, 66(2):115–132.
3.Villalobos P, Wistuba, II: Lung Cancer Biomarkers. Hematol Oncol Clin North Am 2017, 31(1):13–29.
4.Toyooka S, Mitsudomi T, Soh J, Aokage K, Yamane M, Oto T, Kiura K, Miyoshi S: Molecular oncology of lung cancer. Gen Thorac Cardiovasc Surg 2011, 59(8):527–537.
5.Tsao AS, Scagliotti GV, Bunn PA, Jr., Carbone DP, Warren GW, Bai C, de Koning HJ, Yousaf-Khan AU, McWilliams A, Tsao MS et al: Scientific Advances in Lung Cancer 2015. Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer 2016, 11(5):613–638.
6.Zhu QG, Zhang SM, Ding XX, He B, Zhang HQ: Driver genes in non-small cell lung cancer: Characteristics, detection methods, and targeted therapies. Oncotarget 2017, 8(34):57680–57692.
7.Nagano T, Tachihara M, Nishimura Y: Molecular Mechanisms and Targeted Therapies Including Immunotherapy for Non-Small Cell Lung Cancer. Current cancer drug targets 2018.
8.Black RC, Khurshid H: NSCLC: An Update of Driver Mutations, Their Role in Pathogenesis and Clinical Significance. Rhode Island medical journal (2013) 2015, 98(10):25–28.
9.Seijo LM, Peled N, Ajona D, Boeri M, Field JK, Sozzi G, Pio R, Zulueta JJ, Spira A, Massion PP et al: Biomarkers in lung cancer screening: achievements, promises and challenges. Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer 2018.
10.Odunuga OO, Longshaw VM, Blatch GL: Hop: more than an Hsp70/Hsp90 adaptor protein. BioEssays: news and reviews in molecular, cellular and developmental biology 2004, 26(10):1058–1068.
11.Luo X, Liu Y, Ma S, Liu L, Xie R, Li M, Shen P, Wang S: STIP1 is over-expressed in hepatocellular carcinoma and promotes the growth and migration of cancer cells. Gene 2018, 662:110–117.
12.Zhang Z, Ren H, Yang L, Zhang X, Liang W, Wu H, Huang L, Kang J, Xu J, Zhai E et al: Aberrant expression of stress-induced phosphoprotein 1 in colorectal cancer and its clinicopathologic significance. Human pathology 2018, 79:135–143.
13.Pennisi R, Ascenzi P, di Masi A: Hsp90: a new player in DNA repair? Biomolecules 2015, 5(4):2589–2618.
14.Verma S, Goyal S, Jamal S, Singh A, Grover A: Hsp90: Friends, clients and natural foes. Biochimie 2016, 127:227–240.
15.Whitesell L, Lindquist SL: HSP90 and the chaperoning of cancer. Nat Rev Cancer 2005, 5(10):761–772.
16.Lianos GD, Alexiou GA, Mangano A, Rausei S, Boni L, Dionigi G, Roukos DH: The role of heat shock proteins in cancer. Cancer Lett 2015, 360(2):114–118.
17.Liu B, Wan Z, Sheng B, Lin Y, Fu T, Zeng Q, Qi C: Overexpression of EMMPRIN is associated with lymph node metastasis and advanced stage of non-small cell lung cancer: a retrospective study. BMC pulmonary medicine 2017, 17(1):214.
18.Lemjabbar-Alaoui H, Hassan OU, Yang YW, Buchanan P: Lung cancer: Biology and treatment options. Biochim Biophys Acta 2015, 1856(2):189–210.
19.Hirsch FR, Scagliotti GV, Mulshine JL, Kwon R, Curran WJ, Jr., Wu YL, Paz-Ares L: Lung cancer: current therapies and new targeted treatments. Lancet 2016.
20.Wu R, Liu F, Peng P, Qiu H, Xiong H, Yu S, Huang X, Zhang H, Zhuang L: Tumor stress-induced phosphoprotein 1 as a prognostic biomarker for breast cancer. Annals of translational medicine 2018, 6(15):302.
21.Chao A, Lai CH, Tsai CL, Hsueh S, Hsueh C, Lin CY, Chou HH, Lin YJ, Chen HW, Chang TC et al: Tumor stress-induced phosphoprotein1 (STIP1) as a prognostic biomarker in ovarian cancer. PloS one 2013, 8(2):e57084.
22.Zhang S, Shao J, Su F: Prognostic significance of STIP1 expression in human cancer: A meta-analysis. Clinica chimica acta; international journal of clinical chemistry 2018, 486:168–176.
23.Tsai CL, Chao A, Jung SM, Tsai CN, Lin CY, Chen SH, Sue SC, Wang TH, Wang HS, Lai CH: Stress-induced phosphoprotein–1 maintains the stability of JAK2 in cancer cells. Oncotarget 2016, 7(31):50548–50563.
24.Chao A, Lee LY, Hsueh C, Lin CY, Tsai CL, Chao AS, Lin CT, Chou HH, Chang TC, Wang TH: Immunohistological analysis of stress-induced phosphoprotein 1 in ovarian cancer patients with low serum cancer antigen 125 levels. Taiwanese journal of obstetrics & gynecology 2013, 52(2):185–191.
25.Biaoxue R, Shuangying Y: Molecular mechanism and targeted therapy of Hsp90 involved in lung cancer: New discoveries and developments (Review). Int J Oncol 2018, 52(2):321–336.
26.Blandin Knight S, Crosbie PA, Balata H, Chudziak J, Hussell T, Dive C: Progress and prospects of early detection in lung cancer. Open Biol 2017, 7(9).
27.Langevin SM, Kratzke RA, Kelsey KT: Epigenetics of Lung Cancer. Transl Res 2015, 165(1):74–90.
28.Larsen JE, Minna JD: Molecular biology of lung cancer: clinical implications. Clin Chest Med 2011, 32(4):703–740.
29.Barrott JJ, Haystead TA: Hsp90, an unlikely ally in the war on cancer. FEBS J 2013, 280(6):1381–1396.
30.Chehab M, Caza T, Skotnicki K, Landas S, Bratslavsky G, Mollapour M, Bourboulia D: Targeting Hsp90 in urothelial carcinoma. Oncotarget 2015, 6(11):8454–8473.
31.Longshaw VM, Chapple JP, Balda MS, Cheetham ME, Blatch GL: Nuclear translocation of the Hsp70/Hsp90 organizing protein mSTI1 is regulated by cell cycle kinases. Journal of cell science 2004, 117(Pt 5):701–710.
32.Yuan MH, Zhou RS, She B, Xu HF, Wang JY, Wei LX: Expression and clinical significance of STIP1 in papillary thyroid carcinoma. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine 2014, 35(3):2391–2395.
33.Wang M, Feng L, Li P, Han N, Gao Y, Xiao T: Hsp90AB1 protein is overexpressed in non-small cell lung cancer tissues and associated with poor prognosis in lung adenocarcinoma patients. Zhongguo Fei Ai Za Zhi 2016, 19(2):64–69.
34.Biaoxue R, Xiling J, Shuanying Y, Wei Z, Xiguang C, Jinsui W, Min Z: Upregulation of Hsp90-beta and annexin A1 correlates with poor survival and lymphatic metastasis in lung cancer patients. J Exp Clin Cancer Res 2012, 31:70.
35.Kim SH, Ji JH, Park KT, Lee JH, Kang KW, Park JH, Hwang SW, Lee EH, Cho YJ, Jeong YY et al: High-level expression of Hsp90beta is associated with poor survival in resectable non-small-cell lung cancer patients. Histopathology 2015, 67(4):509–519.
36.Esfahani K, Cohen V: HSP90 as a novel molecular target in non-small-cell lung cancer. Lung Cancer (Auckland, NZ) 2016, 7:11–17.